Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | 12/26/2025 | 09/26/2025 | 06/27/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.41% | -5.06% | -8.43% | -2.60% | 24.39% |
| Total Depreciation and Amortization | 4.98% | 7.79% | 9.45% | 12.91% | 12.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.62% | 47.90% | 49.08% | 59.66% | 16.10% |
| Change in Net Operating Assets | -107.55% | -292.58% | -130.53% | 69.69% | 78.57% |
| Cash from Operations | -6.00% | -19.39% | -1.27% | 44.29% | 57.22% |
| Capital Expenditure | -63.46% | -26.84% | -11.44% | -21.13% | 10.81% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 100.00% | 99.72% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.66% | -114.74% | -92.83% | -95.58% | 1,899.88% |
| Cash from Investing | 69.38% | 70.88% | 99.59% | 96.30% | -459.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -24.61% | -11.13% | -18.76% | 6.77% | -22.38% |
| Repurchase of Common Stock | -83.74% | -72.61% | -63.89% | 18.38% | 28.25% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.60% | -9.29% | -10.05% | -10.49% | -10.58% |
| Other Financing Activities | 83.05% | 86.87% | 88.81% | 87.76% | -166.83% |
| Cash from Financing | -54.86% | -43.80% | -41.43% | 14.10% | 10.05% |
| Foreign Exchange rate Adjustments | -134.26% | 712.77% | 214.77% | -81.40% | 494.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.86% | -3.41% | 219.49% | 189.76% | -7.43% |